Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa.

Autor: Chu WY; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Verrest L; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Younis BM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., Musa AM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., Mbui J; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya., Mohammed R; Leishmaniasis Research and Treatment Center, University of Gondar, Gondar, Ethiopia., Olobo J; Department of Immunology and Molecular Biology, Makerere University, Kampala, Uganda., Ritmeijer K; Médecins Sans Frontières, Amsterdam, The Netherlands., Monnerat S; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Wasunna M; Drugs for Neglected Diseases initiative, Nairobi, Kenya., Roseboom IC; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Solomos A; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Huitema ADR; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Alves F; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Dorlo TPC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Dec 16; Vol. 230 (6), pp. e1375-e1384.

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.

Autor: Palić S; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Chu WY; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Sundar S; Department of Medicine, Banaras Hindu University, Varanasi, India., Mondal D; Centre for Nutrition and Food Security (CNFS), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh., Das P; Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India., Pandey K; Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India., Raja S; Drugs for Neglected Diseases initiative (DNDi) South Asia, New Delhi, India., Rijal S; Drugs for Neglected Diseases initiative (DNDi) South Asia, New Delhi, India., Roseboom IC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hamadeh A; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Malik PRV; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sjögren E; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.; Pharmetheus AB, Uppsala, Sweden., Alves F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jul 01; Vol. 79 (7), pp. 1547-1554.

Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.

Autor: Roseboom IC; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Rosing H; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Dorlo TPC; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.

Publikováno v: Biomedical chromatography : BMC [Biomed Chromatogr] 2023 Jul; Vol. 37 (7), pp. e5519. Date of Electronic Publication: 2022 Nov 04.

Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue.

Autor: Roseboom IC; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands. Electronic address: i.roseboom@nki.nl., Thijssen B; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rosing H; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands., Alves F; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Sundar S; Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India., Beijnen JH; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands., Dorlo TPC; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: t.dorlo@nki.nl.

Publikováno v: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2022 Aug 15; Vol. 1206, pp. 123354. Date of Electronic Publication: 2022 Jul 04.

Relapsing leishmanial arthritis: report of a tricky localization and evidence of miltefosine diffusion in synovial fluid.

Autor: Contejean A; Université de Paris, Faculté de Médecine, F-75006, Paris, France.; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France., Ayral X; Service de Rhumatologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France., Dorlo TPC; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands., Roseboom IC; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands., Yera H; Université de Paris, Faculté de Médecine, F-75006, Paris, France.; Laboratoire de Parasitologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France., Gana I; Service de Pharmacologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France., Chouchana L; Centre Régional de Pharmacovigilance, Service de Pharmacologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France., Canouï E; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France., Buffet P; Université de Paris, Faculté de Médecine, F-75006, Paris, France., Charlier C; Université de Paris, Faculté de Médecine, F-75006, Paris, France.; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, F-75014, Paris, France.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Sep 15; Vol. 76 (10), pp. 2740-2741.